Choosing between liraglutide, semaglutide, and tirzepatide depends on your individual health goals, medical history, and lifestyle
In a 48-week phase 2 trial of people with obesity or overweight and one weight-related comorbidity without type 2 diabetes, the mean percent weight change was 7.3%, 10.5%, 13.8%, 17.5%, with weekly eloralintide 1 mg, 3 mg, 6 mg, and 9 mg, respectively, compared to 2.3% with placebo (Table 1) [40]
Continued support from healthcare professionals can also provide strategies and adjustments to sustain your long-term health goals
(By contrast, less than 4% of people who were taking Ozempic without insulin experienced low blood sugar.) In clinical trials of Wegovy , just over 6% of people experienced hypoglycemianearly three times as many as those taking a placebo
In addition, semaglutide injections help the pancreas release the proper amount of insulin to correspond with blood-sugar levels to create a stable, non-shaky feeling